Related Experiment Video
Updated: May 23, 2026
Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Surgery for distant melanoma metastasis
Anna M Leung1, Danielle M Hari, Donald L Morton
1Department of Surgical Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA.
Abstract:
Traditionally, distant metastatic melanoma has a poor prognosis owing to lack of efficacious, U.S. Food and Drug Administration-approved systemic therapy and the limited use of surgical resection as a therapeutic option. More recently, new biological therapies such as vemurafenib (Zelboraf) and ipilimumab (Yervoy) have shown strong promise and dramatically improved the landscape of stage IV melanoma therapy. Although there are numerous single-institution studies advocating the role for therapeutic surgical intervention, many remain skeptical of nonpalliative surgery for metastatic melanoma. Surgical resection of advanced melanoma has been proven to be effective as long as all disease is removed (R0). Patient selection is paramount. The combination of newer systemic therapies and surgical resection is currently under investigation. Understanding the tumor biology of melanoma and its mechanism of metastatic spread is essential to developing the most efficacious treatment strategy.
Insights
Distant metastatic melanoma treatment is improving with new therapies like vemurafenib and ipilimumab. Surgical resection, when complete (R0), is effective for advanced melanoma, especially when combined with systemic treatments.
Area of Science:
- Oncology
- Surgical Oncology
- Dermatology
Background:
- Metastatic melanoma historically had a poor prognosis due to limited effective treatments.
- Recent advancements include U.S. Food and Drug Administration-approved biological therapies like vemurafenib and ipilimumab, significantly improving stage IV melanoma outcomes.
Purpose of the Study:
- To evaluate the role of surgical resection in managing advanced metastatic melanoma.
- To explore the combination of systemic therapies and surgical intervention for stage IV melanoma.
Main Methods:
- Review of single-institution studies advocating for therapeutic surgical intervention in metastatic melanoma.
- Analysis of factors influencing the efficacy of surgical resection, emphasizing complete disease removal (R0).
Main Results:
- Surgical resection can be effective in advanced melanoma if all disease is removed (R0).
- Patient selection is critical for successful surgical outcomes in metastatic melanoma.
- The combination of novel systemic therapies and surgical resection is an area of ongoing investigation.
Conclusions:
- New biological therapies have transformed stage IV melanoma treatment.
- Surgical resection, when R0, remains a viable option for advanced melanoma, particularly when combined with systemic treatments.
- Further understanding of melanoma tumor biology and metastasis is essential for optimizing treatment strategies.
